scholarly journals STUDIES ON THROMBIN-INDUCED PLATELET AGGLUTINATION

1961 ◽  
Vol 114 (6) ◽  
pp. 905-920 ◽  
Author(s):  
Richard W. Shermer ◽  
Reginald G. Mason ◽  
Robert H. Wagner ◽  
Kenneth M. Brinkhous

A one-stage macroscopic test for platelet agglutination was used to study the effect of thrombin and thrombin-cation mixtures on washed platelets. Conclusions regarding platelet agglutination are as follows: (a) Canine, bovine, or human thrombin alone does not cause agglutination of canine or human platelets. (b) Thrombin with calcium or magnesium causes rapid platelet agglutination. Both calcium and magnesium are active at physiologic concentrations. Divalent manganese or cadmium ions can be substituted for calcium or magnesium. (c) The agglutination reaction is affected but little by the species of origin of thrombin or platelets, or by variations in ionic strength or pH over a broad range. (d) Temperature at which the reaction is carried out is critical; optimal temperature for the test is 28°C. (e) Agglutination is inhibited by high ionic strength, by pH values outside the range 6.4–8.6, and by temperatures outside the range 25–28°C. High concentrations of calcium have a specific inhibitory effect. (f) Platelet agglutination time is as sensitive an index of thrombin concentration as is the fibrinogen clotting time. A comparison is made between divalent cations which influence platelet agglutination induced by thrombin, TAg', and TAg. A similar comparison is made of cations influencing the action of thrombin on the "substrates," fibrinogen, TAMe, and platelets.

1979 ◽  
Author(s):  
P. Andersen ◽  
C. Eika

α1-Acid glycoprotein (α1,-acid GP) isolated from human plasma was found to inhibit thrombin-induced aggregation of washed human platelets (0.05 NIH U/ml final conc.), and inhibition was complete with physiological concentrations of α1-acid GP (1.0-1.5 g/1 final conc.). The inhibitory effect seemed to occur immediately on thrombin addition, thus similar to the effect of heparin previously observed. As opposed to heparin, however, α1-acid GP did not affect spontaneous platelet aggregation. Furthermore, α1-acid GP (in optimal cone.) reduced the combined inhibitory effect of heparin and antithrombin III on thrombin-induced platelet aggregation, thus consistent with the previous findings using heparin thrombin clotting time.Snyder and Coodley (1976) found α1-acid GP to inhibit platelet aggregation induced by epinephrine and adenosine diphosphate in platelet-rich plasma. As we also found α1-acid GP to inhibit collagen-induced platelet aggregation, α1-acid GP may possibly act as an inhibitor of the release reaction though fairly high concentrations (10 mg/ml final cone.) was needed for complete inhibition.


1977 ◽  
Author(s):  
J. D. Geratz ◽  
R. R. Tidwell ◽  
K. M. Brinkhous ◽  
S. F. Mohammad

A series of aromatic amidino compounds were investigated for their inhibitory effect on platelet agglutination and platelet aggregation. Agglutination of fresh or fixed human platelets was produced by bovine plasma or by human plasma in combination with ristocetin, while aggregation of fresh platelets was induced by ADP, thrombin or collagen. Highly effective inhibitors were found for both types of platelet clumping, but there was no parallelism between the inhibitory activities in the two test systems.5-(5-Amidino-2-benzimidazolyl)-2-(4-hydroxybenzene)benzimidazole suppressed agglutination exclusively. Pentamidine, on the other hand, strongly blocked the aggregation reactions, but did not interfere with agglutination, even at high concentrations. Compounds which inhibited aggregation also prevented the liberation of serotonin from the platelets.This investigation has led to the identification of new specific inhibitors of platelet agglutination and aggregation which can serve an important role in future studies of the two processes. The exact mode of interaction between ami dines and platelets is still being explored.. In the case of agglutination, inhibition most likely occurred at the level of binding of ristocetin cofactor to the platelet membrane. In the case of aggregation, however, interference could have taken place at the membranes or in the cytoplasm and could have been enzymatic or non-enzymatic in nature.


2002 ◽  
Vol 277 (51) ◽  
pp. 50098-50111 ◽  
Author(s):  
Shaohu Sheng ◽  
Clint J. Perry ◽  
Thomas R. Kleyman

Epithelial sodium channels (ENaC) are regulated by various intracellular and extracellular factors including divalent cations. We studied the inhibitory effect and mechanism of external Ni2+on cloned mouse α-β-γ ENaC expressed inXenopusoocytes. Ni2+reduced amiloride-sensitive Na+currents of the wild type mouse ENaC in a dose-dependent manner. The Ni2+block was fast and partially reversible at low concentrations and irreversible at high concentrations. ENaC inhibition by Ni2+was accompanied by moderate inward rectification at concentrations higher than 0.1 mm. ENaC currents were also blocked by the histidine-reactive reagent diethyl pyrocarbonate. Pretreatment of the oocytes with the reagent reduced Ni2+inhibition of the remaining current. Mutations at αHis282and γHis239located within the extracellular loops significantly decreased Ni2+inhibition of ENaC currents. The mutation αH282D or double mutations αH282R/γH239R eliminated Ni2+block. All mutations at γHis239eliminated Ni2+-induced inward current rectification. Ni2+block was significantly enhanced by introduction of a histidine at αArg280. Lowering extracellular pH to 5.5 and 4.4 decreased or eliminated Ni2+block. Although αH282C-β-γ channels were partially inhibited by the sulfhydryl-reactive reagent [2-(trimethylammonium)ethyl] methanethiosulfonate bromide (MTSET), α-β-γ H239C channels were insensitive to MTSET. From patch clamp studies, Ni2+did not affect unitary current but decreased open probability when perfused into the recording pipette. Our results suggest that external Ni2+reduces ENaC open probability by binding to a site consisting of αHis282and γHis239and that these histidine residues may participate in ENaC gating.


1976 ◽  
Vol 35 (01) ◽  
pp. 202-210 ◽  
Author(s):  
Phyllis S. Roberts ◽  
Haywood N. Hughes ◽  
Patricia B. Fleming

SummaryShorter clotting times were found in the presence of 50 mM Hepes (N-2-hydroxyethylpiper-azine-N1-2-ethanesulfonic acid) buffer than of 50 mM Imidazole buffer in one-stage assays of factors V and VIII, in modified APTT and PT tests and in tests of the clotting of human plasma by purified human thrombin. All tests were performed at ionic strength 0.155 in the presence of either Hepes. NaOH or Imidazole. HC1 buffer, pH 7.4 at 37°. The faster clotting in the presence of Hepes buffer, therefore, is probably due, at least in part, to acceleration by Hepes of thrombin’s enzymatic action on fibrinogen and/or of the polymerization of the fibrin monomers.Hepes may also have effects on other blood clotting reactions. Rates of hydrolysis of TAME or BAME (p-toluenesulfonyl-or benzoyl-L-arginine methyl ester) at pH 7.4, 37° by purified human or bovine thrombin were essentially the same in 200 mM Hepes as in 250 mM Tris. HQ buffer (rates in Hepes. NaOH or Hepes. KOH buffers were compared with those in Tris. HQ plus NaCl for KC1). However, with purified bovine thrombokinase, rates of TAME hydrolysis in Hepes buffer were accelerated and rates of BAME hydrolysis slightly inhibited. Hepes, therefore, reacts with thrombokinase but whether this accelerates (or inhibits) the rate of converting prothrombin to thrombin remains to be determined. In addition, Hepes has an inhibitory effect on clotting since increasing the concentration of Hepes from 50 mM to 200 mM inhibits clotting in the PT, APTT and bovine thrombin-human plasma tests.Hepes buffer is being added to some plasmas and to some reagents used in clotting tests. It is, therefore, important to realize that its concentration must be monitored closely or erroneous results may be obtained in clotting tests and assays of clotting factors.The clotting times were the same in the presence of 50 mM Tris. HC1 as in Imidazole. HC1 buffers in APTT tests at three ionic strengths but they differed slightly in plasma-thrombin tests. Depending upon the ionic strength, 17 mM Barbital Sodium. HC1 buffer inhibited APTT tests but accelerated plasma-thrombin tests. All the buffers tested, therefore, have individual effects on the clotting tests.


MRS Advances ◽  
2017 ◽  
Vol 2 (13) ◽  
pp. 747-752 ◽  
Author(s):  
Sungtae Kim ◽  
Justin Dean ◽  
Jandi Knox ◽  
Leslie Kirkes ◽  
Je-Hun Jang

ABSTRACTWhile conducting siderite (FeCO3) solubility experiments in NaCl-Na2CO3 brines, evidence for a second phase was detected. Experiments, in which synthesized siderite was reacted with high ionic strength (0.18 – 7.5 m) solutions at room temperature and high pH (>10), were conducted in a glovebox. As the aging time of siderite-bearing experiments increased, the pH of the solution decreased, signaling formation of a hydroxyl-bearing phase. Decreasing pH values are interpreted to indicate that a hydroxyl-bearing phase, such as chukanovite, is the reaction controlling solid in the solid assemblage. Chukanovite was tentatively identified by XRD analysis. We set out, therefore, to determine the thermodynamic stability of chukanovite under the experimental conditions. Aqueous thermodynamic model parameters were determined with experimentally analyzed Fe(II) solubility data, and subsequently yielded a proposed formation free energy of chukanovite (-1149.8 kJ/mol).


1977 ◽  
Vol 25 (1) ◽  
pp. 387-402
Author(s):  
J.S. Condeelis

Synthetic myosin thick filaments were formed from preparations of electrophoretically homogeneous myosin isolated from Chaos carolinensis and Amoeba proteus when dialysed to physiological ionic strength and pH. Myosin dialysed directly against low ionic strength buffers formed native-like thick filaments in the presence and absence of exogenous divalent cations. The average dimensions of the synthetic filaments grown under these conditions were 455 nm long and 16 nm wide with a distinct bare central zone 174 nm long. Myosin predialysed against EGTA-EDTA solutions at high ionic strength and then dialysed to low ionic strength formed native-like filaments only in the presence of 1mM Mg2+. 1 mM Ca2+ could not be substituted for Mg2+ under these conditions to achieve native-like filaments. Filaments grown from predialysed myosin in the absence of Mg2+ resembled EGTA-dissociated myosin filaments observed in EGTA-treated cytoplasm and were highly branched, poorly formed filaments lacking a distinct bare central zone. The average dimensions of the filaments grown from predialysed myosin in the absence of Mg2+ were 328 nm long, 13 nm wide with a bare central zone 111 nm long. Under the conditions tested, myosin isolated from these amoebae did not demonstrate a divalent cation requirement for thick filament formation. The results obtained with myosin isolated from the 2 organisms were identical.


1972 ◽  
Vol 27 (03) ◽  
pp. 573-583 ◽  
Author(s):  
Phyllis S. Roberts ◽  
Patricia B. Fleming

SummaryThe effects of varying concentrations of alkali chlorides (LiCl, NaCl, KC1, RbCl and CsCl), alkaline earth chlorides (BeCl2, MgCl2, CaCl2, SrCl2, and BaCl2), choline chloride and Tris,HCl (pH 8.0 at 37°) on the rates of hydrolysis of TAME by a purified preparation of human thrombin and of bovine thrombokinase were determined in 0.25 M Tris.HCl buffer, pH 8.0 at 37°. Each salt had its own individual effects on the reactions and these effects were completely different when thrombin instead of thrombokinase was used. Each salt, however, had the same qualitative effects on TAME hydrolysis by crude bovine thrombin as by purified human thrombin, but only minor effects on the hydrolysis of TAME by trypsin.With the exception of LiCl, low concentrations of alkali chlorides had inhibitory and high concentrations had acceleratory effects on both the thrombin-TAME and the thrombokinase-TAME reactions. LiCl had no accelerating effects on either reaction and it was a stronger inhibitor of thrombokinase than of thrombin. In contrast to the alkali chlorides, the alkaline earth chlorides had no acceleratory effects but had inhibitory effects on both reactions. MgCl2, however, was an exception. It weakly accelerated the thrombokinase -TAME and weakly inhibited the thrombin -TAME reaction. When comparing 0.15 M concentrations of the salts (with the exception of BeCl2 which was the strongest inhibitor of both reactions), NaCl was the strongest inhibitor of the thrombin - TAME reaction, followed by CaCl2, but BaCl2 was the strongest inhibitor of the thrombokinase -TAME reaction, followed by KC1 and LiCl.Choline chloride and Tris.HCl in concentrations up to 3 M had no significant effects on the rate of hydrolysis of TAME by either human or bovine thrombin. Increasing the ionic strength above 0.16 (lower values were not tested), therefore, may have no effect on this reaction, and all of the inhibitions and accelerations found in the presence of the alkali chlorides or the alkaline earth chlorides may be entirely due to the individual cations. On the other hand, increasing the ionic strength may produce a small inhibitory effect, as found in the presence of LiCl or MgCl2, and the lack of any effect in presence of even large concentrations of Tris.HCl or choline chloride may be due to a fortuitous balancing of the weak inhibitory effect of ionic strength by the weak acceleratory effect of the choline and Tris cations.Choline chloride and Tris.HCl had no inhibitory effects but accelerated the thrombokinase -TAME reaction. Choline chloride was the strongest accelerator tested. Rates in the presence of 0.15 and 3 M choline chloride were respectively 204 and 601 % of the controls. Although the effects of ionic strength changes on this reaction could not be established, the data indicate that increasing the ionic strength has at most only a small effect, and the inhibitions and accelerations found are due primarily to the specific cations present.


1983 ◽  
Vol 216 (1) ◽  
pp. 43-49 ◽  
Author(s):  
D G Hassall ◽  
J S Owen ◽  
K R Bruckdorfer

Addition of prostacyclin (PGI2) temporarily inhibits platelet aggregation and permits the isolation of platelets free from plasma proteins, which have the same sensitivity as those in plasma [Moncada, Radomski & Vargas (1982) Br. J. Pharmacol. 75, 165P]. By using a modification of this technique we have established that platelets isolated from normal subjects aggregate more readily in response to ADP and adrenaline when physiological concentrations of low-density lipoproteins (LDL) are present. At high LDL concentrations spontaneous aggregation occurs. High-density lipoproteins (HDL) and very-low-density lipoproteins (VLDL) had no effect on agonist-induced platelet aggregation at normal concentrations, but HDL sensitized at higher concentrations. These effects by lipoproteins are not accompanied by changes in platelet lipid content. Cyclohexanedione treatment of LDL to modify apolipoproteins appeared to abolish the sensitization effect, indicating that binding to receptors was essential for the effects of LDL. LDL, but not HDL, overcame the inhibitory effect of PGI2 on platelet aggregation, except at very high concentrations of PGI2. PGI2 raised the cyclic AMP content of isolated platelets, but LDL only partially prevented this rise. These results suggest that LDL may have a greater role in platelet aggregation than previously recognized and may also regulate effects of PGI2. These findings may be of relevance to an understanding of cardiovascular diseases.


1991 ◽  
Vol 280 (1) ◽  
pp. 39-44
Author(s):  
S M Pemrick ◽  
P A Martinez

In the absence of troponin and tropomyosin, skeletal actomyosin MgATPase activity can be altered by 2-3-fold by divalent cations. The ‘sign’ of this effect (i.e. inhibition or activation) varies with ionic strength. To investigate the mechanism, P(i) liberation was analysed at both low and high ionic strength with three concentrations of MgATP and over a wide range of Mg2+ concentrations. This procedure separated the effects of two dependent variables, Mg2+ and ATP4-/3- (ATPfree), to provide the following observations. (1) ATPfree, not Mg2+ (nor Ca2+), was the modifier. (2) ATPfree was an activator at low ionic strength and an inhibitor at high ionic strength, with half-maximal activation/inhibition occurring between 0.75 and 0.8 mM-ATPfree. (3) The rate constants controlling Vmax. with respect to actin were increased up to 3-fold by ATPfree at low ionic strength, and decreased up to 3-fold by ATPfree at high ionic strength. (4) The effect of ATPfree required near-native levels of the LC2 light chain bound to myosin (i.e. 2 mol of LC2/mol of myosin). (5) Sensitivity of P(i) liberation to a 50% decrease in the LC2 content of myosin required high ATPfree concentrations. It is concluded that LC2 and ATPfree are interdependent, non-additive, modifiers of MgATPase. These results are consistent with thin filament regulation of skeletal muscle contraction, and begin to explain why both positive and negative effects on MgATPase have been attributed to LC2.


Blood ◽  
1956 ◽  
Vol 11 (10) ◽  
pp. 910-915 ◽  
Author(s):  
EDMUND KLEIN ◽  
SIDNEY FARBER ◽  
GUSTAVE FREEMAN ◽  
ROSEMARY FIORENTINO

Abstract Human platelets and their stored, frozen and lyophilized derivatives do not excessively promote coagulation, as indicated by the calcium clotting time. High concentrations of platelet material inhibit coagulation, while dilution to physiologic levels returns the recalcification time to normal values.


Sign in / Sign up

Export Citation Format

Share Document